Closed
Biotech – September 2026
International biotech R&D collaboration support
Record updated
- Funding available
- $ 500,000
- Up to 80% of project cost
- Deadline
- Unspecified
- Location
- Canada
- Who can apply
- Organisations participating in a Network projects consortium under Eureka.
- See full eligibility
Overview
Biotech – September 2026 supports international R&D collaboration in biotechnology for companies and research organisations across participating countries. It focuses on innovative products, processes, and services in fields such as medicine, bioinformatics, pharmaceutical products and services, life sciences, digitalisation, and (bio)process technology.
At a glance
Funding available
- Maximum funding
- $500,000
- Maximum share of project costs
- 80%
- Develop strategic partnerships
- Develop a new product or service
- Conduct research and development activities
- Access new markets
Eligible candidates
- Location
- Canada
- Eligible Industries
- All industries
- Annual revenue
- All revenue ranges
- Organisation size
- All organization sizes
- Audience
- Startups
- Legal structures
- Non-financial cooperative
Receipt of requests is now closed
Get notified about updates to this grant.
Availability timeline
2026
Periods: 3
Eligibility
Who is eligible?
- Organisations participating in a Network projects consortium under Eureka.
Eligible expenses
- R&D costs
- Staff and other costs related to development projects
- Staff and other costs related to research projects
- Salaries costs
- Contractor fees
Activities funded
- Researching or developing an innovative product, process, or service
- Biotech-related cooperation projects with a clear implementation plan
- Projects in areas such as medicine, bioinformatics, pharmaceutical products and services, life sciences, digitalisation, or (bio)process technology
How to apply
- Contact your national funding body to discuss your project idea, financial viability, eligibility, and national procedures.
- Create an account on the Eureka Network application portal and select the funding opportunity.
- Complete one application form per consortium in English and invite other consortium partners to fill in a partner form.
- Upload a GANTT chart, a signed and completed co-signature form, and any additional required annexes.
- Complete and sign a consortium agreement as the final step.
Documents Needed
- GANTT chart
- Signed co-signature form
- Draft consortium agreement, where available
- Project budget
- CV for the Swedish project coordinator
Selection criteria
- Impact
- Excellence
- Quality and efficiency of implementation
- Overall perception
Processing and Agreement
- Applications will be checked for completeness and eligibility before review under a standard evaluation procedure.
- If successful, the project will receive a Eureka label.
- The national funding body may carry out a further evaluation according to national rules before allocating funds.
- The final step is to complete and sign a consortium agreement.
Additional information
- The call runs from 31 March 2026 to 25 September 2026.
- National funding procedures are expected to be finalised by Q1 2027.
- Projects can start in Q2 2027.
- The application is submitted through Eureka Smart Simple, with additional national steps required by participating countries.
Contacts
Official sources
Frequently Asked Questions about the Biotech – September 2026 Program
What is the Biotech – September 2026?
Biotech – September 2026 supports international R&D collaboration in biotechnology for companies and research organisations across participating countries. It focuses on innovative products, processes, and services in fields such as medicine, bioinformatics, pharmaceutical products and services, life sciences, digitalisation, and (bio)process technology.
How much funding can be received?
Biotech – September 2026 Funds up to 80% of admissible expenses, capped at $500,000 per project.
Who is eligible for the Biotech – September 2026 program?
To be eligible for the Biotech – September 2026 program, you must:
The project must involve international cooperation as a specific project.
The project must target an innovative product, process, or service with commercialisation as the goal.
The consortium must include at least two independent legal entities from at least two Eureka Call participating countries.
What expenses are eligible under Biotech – September 2026?
R&D costs
Staff and other costs related to development projects
Staff and other costs related to research projects
Salaries costs
Contractor fees
Who can I contact for more information about the Biotech – September 2026?
You can contact Eureka Network (EUREKA) by email at eureka@innosuisse.ch or by phone at +41 58 343 60 33.
Where is the Biotech – September 2026 available?
The Biotech – September 2026 program is available across Canada.
Is the Biotech – September 2026 a grant, loan, or tax credit?
Biotech – September 2026 is a Grant and Funding